News Notes

Mouse Modelers' Marriage To unite the efforts of scientists working to develop mouse models of human cancers, the National Cancer Institute (NCI) recently formed a consortium of 19 top-tier groups of cancer investigators hailing from more than 30 institutions. Driven by NCI funds, $4.5 million for the first six months and a total commitment of $15 million, it's an experimental arrangement that could become a model for future programs. The consortium will establish a repository for mouse models,

Written byEugene Russo
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Mouse Modelers' Marriage

To unite the efforts of scientists working to develop mouse models of human cancers, the National Cancer Institute (NCI) recently formed a consortium of 19 top-tier groups of cancer investigators hailing from more than 30 institutions. Driven by NCI funds, $4.5 million for the first six months and a total commitment of $15 million, it's an experimental arrangement that could become a model for future programs. The consortium will establish a repository for mouse models, sperm, and cryopreserved embryos, as well as a common database for mouse model data on cancer-related genes and pathways, model validity, new approaches to detection and diagnosis, and new ways to evaluate prevention and treatment. Both the database and the repository will be accessible to the entire scientific community. Consortium labs will, however, continue to work on their respective projects separately. According to the director of NCI's Division of Cancer Biology, Dinah ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies